성인 백신 시장 : 백신별, 백신 유형별, 기술별, 지역별

Global Adult Vaccines Market is estimated to be valued at USD 19.66 Bn in 2025 and is expected to reach USD 35.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2032.

Figure. Adult Vaccines Market Share (%), By Region 2025

Global adult vaccines market growth is driven by increasing investments by governments and private firms in adult vaccination programs. Adult vaccinations have gained popularity as these protect vulnerable groups from serious diseases and infections. Growing awareness about available vaccines and their benefits for adults has prompted more individuals to get vaccinated. Moreover, expansion of indications for existing adult vaccines and development of new formulations have strengthened prevention against various diseases affecting the adult population worldwide. However, high development costs and lack of adequate vaccination infrastructure in developing nations can hamper the market growth.

Market Dynamics:

Global adult vaccines market growth is driven by rising prevalence of diseases such as influenza, meningococcal meningitis, pneumococcal infection, and others among adults. According to the World Health Organization, seasonal influenza results in severe illness in around 3-5 million cases and 290,000-650,000 respiratory deaths globally every year. Increasing healthcare expenditures, favorable government support through vaccination programs and introduction of novel vaccines can drive the market growth. However, low awareness in developing countries, high R&D costs associated with development of new vaccines and storage requirements can hamper the market growth. Development of thermostable vaccines without refrigeration needs and combined adult vaccine formulations can offer opportunities for market players.

Key Features of the Study:

• This report provides in-depth analysis of the global adult vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global adult vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GlaxoSmithKline, Sanofi Pasteur, Merck, Novavax, Pfizer, and CSL Limited
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global adult vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global adult vaccines market

Detailed Segmentation-

• By Vaccines
  • Influenza
  • Tetanus, Diphtheria, Pertussis (Td/Tdap)
  • Varicella
  • Human Papillomavirus
  • Zoster
  • Measles, Mumps, Rubella (MMR)
  • Pneumococcal
  • Hepatitis
  • Others
• By Vaccine Type
  • Monovalent
  • Multivalent
• By Technology
  • Live Attenuated Vaccines
  • Inactivated Viral/Bacterial Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Conjugate Vaccines
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi Pasteur
  • AstraZeneca
  • Johnson & Johnson
  • Novavax, Inc.
  • Moderna, Inc.
  • Inovio Pharmaceuticals, Inc.
  • Bavarian Nordic
  • Dynavax Technologies Corporation
  • BioNTech S
  • Emergent BioSolutions Inc.
  • Serum Institute of India Pvt. Ltd.
  • Bharat Biotech
  • Sinovac Biotech Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Vaccines
  • Market Snapshot, By Vaccine Type
  • Market Snapshot, By Technology
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Adult Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Adult Vaccines Market, By Vaccines, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Influenza
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tetanus, Diphtheria, Pertussis (Td/Tdap)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Varicella
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Human Papillomavirus
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Zoster
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Measles, Mumps, Rubella (MMR)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pneumococcal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hepatitis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Adult Vaccines Market, By Vaccine Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Monovalent
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Multivalent
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Adult Vaccines Market, By Technology, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Live Attenuated Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inactivated Viral/Bacterial Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Toxoid Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Recombinant Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Conjugate Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Adult Vaccines Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • GlaxoSmithKline plc
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi Pasteur
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AstraZeneca
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novavax, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Moderna, Inc.
  • Inovio Pharmaceuticals, Inc.
  • Bavarian Nordic
  • Dynavax Technologies Corporation
  • BioNTech S
  • Emergent BioSolutions Inc.
  • Serum Institute of India Pvt. Ltd.
  • Bharat Biotech
  • Sinovac Biotech Ltd.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact